Proteins > DNA gyrase subunit A
Page last updated: 2024-08-07 15:50:56
DNA gyrase subunit A
A DNA gyrase subunit A that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0AES4]
Synonyms
EC 5.6.2.2
Research
Bioassay Publications (37)
Timeframe | Studies on this Protein(%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (24.32) | 29.6817 |
2010's | 17 (45.95) | 24.3611 |
2020's | 11 (29.73) | 2.80 |
Compounds (18)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
ciprofloxacin | Escherichia coli K-12 | IC50 | 5.5934 | 26 | 26 |
enoxacin | Escherichia coli K-12 | IC50 | 14.0000 | 1 | 1 |
isoniazid | Escherichia coli K-12 | IC50 | 1,000.0000 | 1 | 1 |
nalidixic acid | Escherichia coli K-12 | IC50 | 157.5000 | 2 | 2 |
norfloxacin | Escherichia coli K-12 | IC50 | 9.6000 | 2 | 2 |
ofloxacin | Escherichia coli K-12 | IC50 | 1.5000 | 1 | 1 |
gatifloxacin | Escherichia coli K-12 | IC50 | 0.5000 | 2 | 2 |
triclosan | Escherichia coli K-12 | IC50 | 1,000.0000 | 1 | 1 |
4-cumylphenol | Escherichia coli K-12 | IC50 | 390.0000 | 1 | 1 |
4-phenoxyphenol | Escherichia coli K-12 | IC50 | 530.0000 | 1 | 1 |
bis(4-oxyphenyl)sulfide | Escherichia coli K-12 | IC50 | 950.0000 | 1 | 1 |
moxifloxacin | Escherichia coli K-12 | IC50 | 1.4000 | 2 | 2 |
linezolid | Escherichia coli K-12 | IC50 | 32.0000 | 1 | 1 |
gemifloxacin | Escherichia coli K-12 | IC50 | 0.5000 | 1 | 1 |
pd 0305970 | Escherichia coli K-12 | IC50 | 0.2000 | 2 | 2 |
gsk299423 | Escherichia coli K-12 | IC50 | 0.1000 | 1 | 1 |
novobiocin | Escherichia coli K-12 | IC50 | 0.1441 | 10 | 10 |
novobiocin | Escherichia coli K-12 | Ki | 0.0447 | 1 | 3 |
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
ciprofloxacin | Escherichia coli K-12 | Activity | 10.7200 | 4 | 4 |
ciprofloxacin | Escherichia coli K-12 | EC | 1.2000 | 1 | 1 |
ofloxacin | Escherichia coli K-12 | CC25 | 0.2000 | 1 | 1 |
moxifloxacin | Escherichia coli K-12 | CC25 | 0.5000 | 1 | 1 |
novobiocin | Escherichia coli K-12 | Activity | 3.1000 | 1 | 1 |
clorobiocin | Escherichia coli K-12 | Activity | 1.6000 | 1 | 1 |
Solid-phase synthesis and biological evaluation of piperazine-based novel bacterial topoisomerase inhibitors.
Bioorganic & medicinal chemistry letters, , 02-01, Volume: 57, 2022
Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
European journal of medicinal chemistry, , Jan-15, Volume: 228, 2022
New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus.
Bioorganic & medicinal chemistry, , 11-01, Volume: 73, 2022
Discovery and structure-activity relationships of a novel oxazolidinone class of bacterial type II topoisomerase inhibitors.
Bioorganic & medicinal chemistry letters, , 06-01, Volume: 65, 2022
[no title available]
RSC medicinal chemistry, , Jul-20, Volume: 13, Issue:7, 2022
Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides.
European journal of medicinal chemistry, , May-01, Volume: 193, 2020
Directing Drugs to Bugs: Antibiotic-Carbohydrate Conjugates Targeting Biofilm-Associated Lectins of
Journal of medicinal chemistry, , 10-22, Volume: 63, Issue:20, 2020
Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.
Journal of medicinal chemistry, , 07-23, Volume: 63, Issue:14, 2020
Identification of a potent small-molecule inhibitor of bacterial DNA repair that potentiates quinolone antibiotic activity in methicillin-resistant Staphylococcus aureus.
Bioorganic & medicinal chemistry, , 10-15, Volume: 27, Issue:20, 2019
Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents.
European journal of medicinal chemistry, , Oct-01, Volume: 179, 2019
Virtual Screening Approach and Investigation of Structure-Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens.
Journal of medicinal chemistry, , 08-22, Volume: 62, Issue:16, 2019
Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative Bacteria.
Journal of medicinal chemistry, , 05-24, Volume: 61, Issue:10, 2018
Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.
Journal of medicinal chemistry, , 04-26, Volume: 61, Issue:8, 2018
Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase.
MedChemComm, , Volume: 8, Issue:5, 2017
Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids.
European journal of medicinal chemistry, , Jun-05, Volume: 97, 2015
Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent.
Bioorganic & medicinal chemistry, , Jul-15, Volume: 22, Issue:14, 2014
Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterization.
Journal of medicinal chemistry, , Nov-13, Volume: 57, Issue:21, 2014
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Journal of medicinal chemistry, , Oct-23, Volume: 57, Issue:20, 2014
Comparison of in vitro activities of fluoroquinolone-like 2,4- and 1,3-diones.
Antimicrobial agents and chemotherapy, , Volume: 54, Issue:7, 2010
DNA gyrase from the albicidin producer Xanthomonas albilineans has multiple-antibiotic-resistance and unusual enzymatic properties.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:4, 2008
Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells.
Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 16, Issue:5, 2006
Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.
Journal of medicinal chemistry, , Jan-12, Volume: 49, Issue:1, 2006
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
Journal of medicinal chemistry, , Nov-02, Volume: 49, Issue:22, 2006
Synthesis and structural-activity relationships of 3-hydroxyquinazoline-2,4-dione antibacterial agents.
Bioorganic & medicinal chemistry letters, , Sep-06, Volume: 14, Issue:17, 2004
Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action.
Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 13, Issue:23, 2003
Bioorganic & medicinal chemistry letters, , 02-01, Volume: 57, 2022
Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
European journal of medicinal chemistry, , Jan-15, Volume: 228, 2022
New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus.
Bioorganic & medicinal chemistry, , 11-01, Volume: 73, 2022
Discovery and structure-activity relationships of a novel oxazolidinone class of bacterial type II topoisomerase inhibitors.
Bioorganic & medicinal chemistry letters, , 06-01, Volume: 65, 2022
[no title available]
RSC medicinal chemistry, , Jul-20, Volume: 13, Issue:7, 2022
Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides.
European journal of medicinal chemistry, , May-01, Volume: 193, 2020
Directing Drugs to Bugs: Antibiotic-Carbohydrate Conjugates Targeting Biofilm-Associated Lectins of
Journal of medicinal chemistry, , 10-22, Volume: 63, Issue:20, 2020
Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.
Journal of medicinal chemistry, , 07-23, Volume: 63, Issue:14, 2020
Identification of a potent small-molecule inhibitor of bacterial DNA repair that potentiates quinolone antibiotic activity in methicillin-resistant Staphylococcus aureus.
Bioorganic & medicinal chemistry, , 10-15, Volume: 27, Issue:20, 2019
Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents.
European journal of medicinal chemistry, , Oct-01, Volume: 179, 2019
Virtual Screening Approach and Investigation of Structure-Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens.
Journal of medicinal chemistry, , 08-22, Volume: 62, Issue:16, 2019
Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multidrug Resistant Gram-negative Bacteria.
Journal of medicinal chemistry, , 05-24, Volume: 61, Issue:10, 2018
Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.
Journal of medicinal chemistry, , 04-26, Volume: 61, Issue:8, 2018
Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase.
MedChemComm, , Volume: 8, Issue:5, 2017
Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids.
European journal of medicinal chemistry, , Jun-05, Volume: 97, 2015
Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent.
Bioorganic & medicinal chemistry, , Jul-15, Volume: 22, Issue:14, 2014
Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterization.
Journal of medicinal chemistry, , Nov-13, Volume: 57, Issue:21, 2014
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Journal of medicinal chemistry, , Oct-23, Volume: 57, Issue:20, 2014
Comparison of in vitro activities of fluoroquinolone-like 2,4- and 1,3-diones.
Antimicrobial agents and chemotherapy, , Volume: 54, Issue:7, 2010
DNA gyrase from the albicidin producer Xanthomonas albilineans has multiple-antibiotic-resistance and unusual enzymatic properties.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:4, 2008
Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells.
Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 16, Issue:5, 2006
Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.
Journal of medicinal chemistry, , Jan-12, Volume: 49, Issue:1, 2006
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
Journal of medicinal chemistry, , Nov-02, Volume: 49, Issue:22, 2006
Synthesis and structural-activity relationships of 3-hydroxyquinazoline-2,4-dione antibacterial agents.
Bioorganic & medicinal chemistry letters, , Sep-06, Volume: 14, Issue:17, 2004
Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action.
Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 13, Issue:23, 2003
Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:8, 2008
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:8, 2008
Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase.
Bioorganic & medicinal chemistry, , 04-15, Volume: 27, Issue:8, 2019
Bioorganic & medicinal chemistry, , 04-15, Volume: 27, Issue:8, 2019
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Journal of medicinal chemistry, , Oct-23, Volume: 57, Issue:20, 2014
Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:8, 2008
Journal of medicinal chemistry, , Oct-23, Volume: 57, Issue:20, 2014
Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:8, 2008
Design and synthesis of aminothiazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation.
European journal of medicinal chemistry, , Apr-01, Volume: 167, 2019
Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.
Journal of medicinal chemistry, , Jan-12, Volume: 49, Issue:1, 2006
European journal of medicinal chemistry, , Apr-01, Volume: 167, 2019
Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.
Journal of medicinal chemistry, , Jan-12, Volume: 49, Issue:1, 2006
Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:8, 2008
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:8, 2008
Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells.
Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 16, Issue:5, 2006
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
Journal of medicinal chemistry, , Nov-02, Volume: 49, Issue:22, 2006
Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 16, Issue:5, 2006
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
Journal of medicinal chemistry, , Nov-02, Volume: 49, Issue:22, 2006
Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase.
Bioorganic & medicinal chemistry, , 04-15, Volume: 27, Issue:8, 2019
Bioorganic & medicinal chemistry, , 04-15, Volume: 27, Issue:8, 2019
Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes.
MedChemComm, , Oct-01, Volume: 9, Issue:10, 2018
MedChemComm, , Oct-01, Volume: 9, Issue:10, 2018
Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes.
MedChemComm, , Oct-01, Volume: 9, Issue:10, 2018
MedChemComm, , Oct-01, Volume: 9, Issue:10, 2018
Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes.
MedChemComm, , Oct-01, Volume: 9, Issue:10, 2018
MedChemComm, , Oct-01, Volume: 9, Issue:10, 2018
Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:8, 2008
Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells.
Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 16, Issue:5, 2006
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:8, 2008
Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells.
Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 16, Issue:5, 2006
Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterization.
Journal of medicinal chemistry, , Nov-13, Volume: 57, Issue:21, 2014
Journal of medicinal chemistry, , Nov-13, Volume: 57, Issue:21, 2014
Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells.
Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 16, Issue:5, 2006
Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 16, Issue:5, 2006
Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.
Journal of medicinal chemistry, , 07-23, Volume: 63, Issue:14, 2020
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
Journal of medicinal chemistry, , Nov-02, Volume: 49, Issue:22, 2006
Journal of medicinal chemistry, , 07-23, Volume: 63, Issue:14, 2020
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
Journal of medicinal chemistry, , Nov-02, Volume: 49, Issue:22, 2006
Virtual Screening Approach and Investigation of Structure-Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens.
Journal of medicinal chemistry, , 08-22, Volume: 62, Issue:16, 2019
Journal of medicinal chemistry, , 08-22, Volume: 62, Issue:16, 2019
New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.
European journal of medicinal chemistry, , Mar-05, Volume: 213, 2021
Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
Bioorganic & medicinal chemistry, , 11-15, Volume: 28, Issue:22, 2020
Exploring the Chemical Space of Benzothiazole-Based DNA Gyrase B Inhibitors.
ACS medicinal chemistry letters, , Dec-10, Volume: 11, Issue:12, 2020
An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
European journal of medicinal chemistry, , Apr-01, Volume: 167, 2019
New
MedChemComm, , Jun-01, Volume: 10, Issue:6, 2019
Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase.
MedChemComm, , Volume: 8, Issue:5, 2017
Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
Journal of medicinal chemistry, , Jul-23, Volume: 58, Issue:14, 2015
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:6, 2008
DNA gyrase from the albicidin producer Xanthomonas albilineans has multiple-antibiotic-resistance and unusual enzymatic properties.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:4, 2008
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
Journal of medicinal chemistry, , Sep-11, Volume: 51, Issue:17, 2008
European journal of medicinal chemistry, , Mar-05, Volume: 213, 2021
Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
Bioorganic & medicinal chemistry, , 11-15, Volume: 28, Issue:22, 2020
Exploring the Chemical Space of Benzothiazole-Based DNA Gyrase B Inhibitors.
ACS medicinal chemistry letters, , Dec-10, Volume: 11, Issue:12, 2020
An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
European journal of medicinal chemistry, , Apr-01, Volume: 167, 2019
New
MedChemComm, , Jun-01, Volume: 10, Issue:6, 2019
Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase.
MedChemComm, , Volume: 8, Issue:5, 2017
Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
Journal of medicinal chemistry, , Jul-23, Volume: 58, Issue:14, 2015
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:6, 2008
DNA gyrase from the albicidin producer Xanthomonas albilineans has multiple-antibiotic-resistance and unusual enzymatic properties.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:4, 2008
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
Journal of medicinal chemistry, , Sep-11, Volume: 51, Issue:17, 2008
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:6, 2008
Antimicrobial agents and chemotherapy, , Volume: 52, Issue:6, 2008